Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.
Clinical trial NCT00338351 · COMPLETED
Trial details
- NCT number
- NCT00338351
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.